Late acute rejection after liver transplantation impacts patient survival

Clinical Transplantation

Volumn 22, Issue 3, 2008, Pages 316-323

  Uemura, Tadahiro ^a   Ikegami, Toru ^a   Sanchez, Edmund Q ^a   Jennings, Linda W ^a   Narasimhan, Gomathy ^a   McKenna, Greg J ^a   Randall, Henry B ^a   Chinnakotla, Srinath ^a   Levy, Marlon F ^a   Goldstein, Robert M ^a   Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Late acute rejection; Patient survival

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGE DISTRIBUTION; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT DISEASE; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FEMALE; GRAFT SURVIVAL; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; INCIDENCE; KIDNEY DYSFUNCTION; LIVER BIOPSY; LIVER TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PERITONITIS; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROGNOSIS; RETRANSPLANTATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; CHOLANGITIS, SCLEROSING; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; METABOLIC DISEASES; PROGNOSIS; REOPERATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 43749119823     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00788.x     Document Type: Article

References (23)

1. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation (1). N Engl J Med 1989: 321: 1014.
2. Rayes N, Seehofer D, Theruvath T et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - a randomized, double-blind trial. Am J Transplant 2005: 5: 125.
3. Mora NP, Husberg BS, Gonwa TA, Goldstein R, Klintmalm GB. The impact of the different severe infections on the outcome of liver transplantation. A study of 150 patients. Transpl Int 1992: 5 (Suppl. 1): S209.
4. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994: 331: 1110.
5. Wiesner RH, Demetris AJ, Belle SH et al. Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 1998: 28: 638.
6. Tippner C, Nashan B, Hoshino K et al. Clinical and subclinical acute rejection early after liver transplantation: Contributing factors and relevance for the long-term course. Transplantation 2001: 72: 1122.
7. Mor E, Gonwa TA, Husberg BS, Goldstein RM, Klintmalm GB. Late-onset acute rejection in orthotopic liver transplantation-associated risk factors and outcome. Transplantation 1992: 54: 821.
8. Cakaloglu Y, Devlin J, O'Grady J et al. Importance of concomitant viral infection during late acute liver allograft rejection. Transplantation 1995: 59: 40.
9. Anand AC, Hubscher SG, Gunson BK, McMaster P, Neuberger JM. Timing, significance, and prognosis of late acute liver allograft rejection. Transplantation 1995: 60: 1098.
10. Dousset B, Conti F, Cherruau B et al. Is acute rejection deleterious to long-term liver allograft function? J Hepatol 1998: 29: 660.
11. Ramji A, Yoshida EM, Bain VG et al. Late acute rejection after liver transplantation: The Western Canada experience. Liver Transpl 2002: 8: 945.
12. Schweizer RT, Rovelli M, Palmeri D, Vossler E, Hull D, Bartus S. Noncompliance in organ transplant recipients. Transplantation 1990: 49: 374.
13. D'Antiga L, Dhawan A, Portmann B et al. Late cellular rejection in paediatric liver transplantation: Aetiology and outcome. Transplantation 2002: 73: 80.
14. Gonwa TA, Mai ML, Melton LB et al. Renal replacement therapy and orthotopic liver transplantation: The role of continuous veno-venous hemodialysis. Transplantation 2001: 71: 1424.
15. Demetris AJ, Batts KP, Dhillon AP et al. Banff schema for grading liver allograft rejection: An international consensus document. Hepatology 1997: 25: 658.
16. Sanchez EQ, Gonwa TA, Levy MF et al. Preoperative and perioperative predictors of the need for renal replacement therapy after orthotopic liver transplantation. Transplantation 2004: 78: 1048.
17. O'Grady JG, Alexander GJ, Sutherland S et al. Cytomegalovirus infection and donor/recipient HLA antigens: Interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation. Lancet 1988: 2: 302.
18. Steinhoff G, Wonigeit K, Pichlmayr R. Analysis of sequential changes in major histocompatibility complex expression in human liver grafts after transplantation. Transplantation 1988: 45: 394.
19. Lautenschlager I, Hockerstedt K, Jalanko H et al. Persistent cytomegalovirus in liver allografts with chronic rejection. Hepatology 1997: 25: 190.
20. Ustinov J, Loginov R, Bruggeman C, Suni J, Hayry P, Lautenschlager I. CMV-induced class II antigen expression in various rat organs. Transpl Int 1994: 7: 302.
21. Duvoux C, Pageaux GP, Vanlemmens C et al. Risk factors for lymphoproliferative disorders after liver transplantation in adults: An analysis of 480 patients. Transplantation 2002: 74: 1103.
22. Florman S, Schiano T, Kim L et al. The incidence and significance of late acute cellular rejection (>1000 days) after liver transplantation. Clin Transplant 2004: 18: 152.
23. Gupta P, Hart J, Cronin D, Kelly S, Millis JM, Brady L. Risk factors for chronic rejection after pediatric liver transplantation. Transplantation 2001: 72: 1098.